Search results
From Self-sufficiency
Page title matches
- ...rom 1967 to 1972 it was known as ''FDA Papers'' before changing title to ''FDA Consumer'' with v.6 #6 (July/August 1972). ...depository library|depository libraries]] which selected to receive it. ''FDA Consumer'' ceased publication with v.41 #2 (March-April 2007), though exist861 bytes (116 words) - 18:09, 9 December 2011
Page text matches
- ...ramps]]. This practice is now considered dubious by the FDA<ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders ...sumers About Off-Label Use of Quinine to Treat Leg Cramps | url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108799.htm | accessdate=27 KB (3,844 words) - 16:41, 27 September 2010
- 1. "At the time this study was conceived, no formal FDA guidelines for neurotoxicity testing existed. In contrast, first-tier neuro The FDA "approval" process in 1970 did not require safety testing for neurotoxicity13 KB (1,807 words) - 16:41, 27 September 2010
- ...(an excess of aluminium in the body) in select patients although it is not FDA approved for this use.5 KB (714 words) - 20:14, 21 September 2010
- | UNII_Ref = {{fdacite|correct|FDA}} ...FDA Approves Narcan Nasal Spray|url = http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html|website = www.jems.com|accessdate = 2015-133 KB (4,541 words) - 10:57, 17 June 2016
- In the United States, the [[Food and Drug Administration|FDA]]-approved indications for carbamazepine use are [[epilepsy]] (including [[ ...for Drugs, Biologics, Medical Devices, and Dietary Supplements |publisher=FDA}}</ref> In Europeans a large proportion of sensitivity is associated with [16 KB (2,164 words) - 16:42, 27 September 2010
- ...ov/fdac/features/2007/107_drug.html |date=January-February 2007 |publisher=FDA Consumer magazine |accessdate=2007-09-27}}</ref>20 KB (2,657 words) - 16:42, 27 September 2010
- ...ilization]], although it has never been approved for those purposes by the FDA. [[Jack Dreyfus]], founder of the [[Dreyfus Fund]], became a major proponen ...at the FDA has identified a potential safety issue, but does not mean that FDA has identified a causal relationship between the drug and the listed risk.12 KB (1,686 words) - 16:42, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) has not approved albendazole for this indication. It is marketed by [[Glax10 KB (1,261 words) - 13:28, 4 September 2010
- ...ef>{{cite web | url = http://www.medscape.com/viewarticle/548709 | title = FDA Approvals: Ziana, Kadian, Polyphenon E | last = Waknine | first = Yael | da25 KB (3,261 words) - 14:17, 11 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approval in 1967, becoming Pfizer's first once-a-day broad-spectrum antibi20 KB (2,578 words) - 16:43, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approved) *[[Crohn's disease]] with colonic or perianal involvement (non-FDA approved){{ndash}} believed to be more effective in combination with [[cipr19 KB (2,528 words) - 16:43, 27 September 2010
- ...of the Council Regulation 2377/90. The [[Food and Drug Administration]] (FDA) of the United States has prohibited [[furaltadone]] since February 1985 an12 KB (1,576 words) - 16:43, 27 September 2010
- ...nd's being fast-tracked for approval by the [[Food and Drug Administration|FDA]] in 1958. Eli Lilly first marketed vancomycin hydrochloride under the trad ...rmacare]] in Australia. The [[patent]] expired in the early 1980s, but the FDA has not authorized the sale of any generic versions in the USA.31 KB (4,198 words) - 16:43, 27 September 2010
- ...government named Clofazimine an [[orphan drug]] in June 1986. Geigy gained FDA approval for the drug in December 1986. ...its immunosuppressive activity even before it was approved for leprosy by FDA. It was first reported to be effective in treating chronic discoid lupus er12 KB (1,651 words) - 16:43, 27 September 2010
- Fluconazole/Diflucan is in the FDA pregnancy category C. <br />This means that it is not known whether it will11 KB (1,533 words) - 16:44, 27 September 2010
- FDA-approved dosing of potassium iodide for this purpose with iobenguane, is as ...s/Guidance%20for%20use%20of%20KI%20for%20nuclear%20emergency%20USG.pdf] US FDA, "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies," U23 KB (3,281 words) - 16:44, 27 September 2010
- Abacavir was approved by the [[Food and Drug Administration]] (FDA) on December 18, 1998 and is thus the fifteenth approved antiretroviral dru A new FDA alert concerning abacavir and abacavir containing medications8 KB (1,124 words) - 16:44, 27 September 2010
- ...ates by the [[Food and Drug Administration]] (FDA) on October 9, 1991. Its FDA approval helped bring down the price of [[zidovudine]] (AZT), the initial a ...oul-tasting and the buffering compound would cause diarrhea. Although the FDA had not approved the original formulation for once-a-day dosing it was poss9 KB (1,239 words) - 16:44, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) on July 12, 2006 under the brand name '''Atripla'''. It was approved by the FDA July 2, 2003. It is very similar to [[3TC]] and cross-resistance between th5 KB (667 words) - 16:44, 27 September 2010
- Lamivudine was approved by the [[Food and Drug Administration]] (FDA) on November 17, 1995 for use with [[zidovudine]] (AZT) and again in 2002 a9 KB (1,248 words) - 16:44, 27 September 2010
- ...um]]. Stavudine was approved by the U.S. [[Food and Drug Administration]] (FDA) in June 24, 1994 for adults and in September 6, 1996 for pediatric use and4 KB (574 words) - 16:44, 27 September 2010
- ...ination of tenofovir, emtricitabine and [[efavirenz]], was approved by the FDA on 12 July 2006 and is now available, providing a single daily dose for the ...nline.wsj.com/article/SB121849463154631469.html?mod=us_business_whats_news FDA Clears Viread for Hepatitis B]</ref>.6 KB (871 words) - 16:45, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in July 2006 under the brand name [[Atripla]], provides HAART in a single Efavirenz was approved by the FDA on September 21, 1998, making it the 14th approved antiretroviral drug.10 KB (1,441 words) - 16:45, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA). It was approved June 21, 1996 for adults and September 11, 1998 for child ...could cause severe liver damage, including liver failure.<ref>[http://www.fda.gov/medwatch/safety/2000/viramune.htm Viramune (nevirapine) letter (Novembe15 KB (2,090 words) - 16:45, 27 September 2010
- The [[Food and Drug Administration]] (FDA) approved indinavir March 13, 1996, making it the eighth approved antiretro3 KB (320 words) - 15:07, 6 July 2010
- Lopinavir/ritonavir was approved by the [[US]] [[Food and Drug Administration|FDA]] on 15 September 2000, and in Europe in April 2001. Its patent will expire ...e Kaletra (lopinavir/ritonavir) with caution <ref name="SafetyLabel200904">FDA Issues Safety Labeling Changes for Kaletra, 2009-04-10, [http://www.medscap8 KB (1,109 words) - 16:45, 27 September 2010
- ...nventions| date=2004-06-03}}.</ref> The [[Food and Drug Administration]] (FDA) approved ritonavir on March 1, 1996, making it the seventh approved antire9 KB (1,233 words) - 15:07, 6 July 2010
- ...$528 in Africa. It was approved by the U.S. [[Food and Drug Administration|FDA]] on July 12, 2006. In the UK, the drug cost to the NHS is {{GB£}}620 per *[http://thebody.com/fda/atripla.html Atripla] article on The Body, an HIV reference site6 KB (773 words) - 16:45, 27 September 2010
- ...nd sixth antiretroviral) approved by the [[Food and Drug Administration]] (FDA). It was approved on December 6, 1995, as Invirase, a poorly-absorbed hard5 KB (717 words) - 15:07, 6 July 2010
- ...icense fees to [[Valeant Pharmaceuticals International]]. The only present FDA-approved indication for these products is in conjunction with interferon ag ...ials against experimental influenza infection were mixed, however, and the FDA ultimately did not approve this indication for ribavirin use in humans, the23 KB (3,222 words) - 16:45, 27 September 2010
- ...Migraine Pain | publisher = [[U.S. Food and Drug Administration]] | work = FDA Consumer magazine | year = 1998}}</ref> ...children. As a result of some lingering concerns about nitrite safety, the FDA and the USDA commissioned a comprehensive review of sodium nitrite's role a21 KB (3,046 words) - 16:45, 27 September 2010
- ...pine has not been officially indicated for either of these purposes by the FDA, it has been used by physicians for these purposes.<ref>[http://www.eperc.m16 KB (2,198 words) - 16:46, 27 September 2010
- The U.S. [[Food and Drug Administration|FDA]] assigned PAS to [[pregnancy category]] C, indicating that it is not known7 KB (879 words) - 16:46, 27 September 2010
- ...States)|Food and Drug Administration]] (FDA) in 1987. Ciprofloxacin has 12 FDA-approved human uses and other veterinary uses, but it is often used for non ...Bayer introduced ciprofloxacin in 1987 and was later approved by the U.S. FDA on 22 October 22 1987 for use in the United States to treat specific bacter88 KB (11,930 words) - 16:46, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approved AzaSite, an ophthalmic formulation of azithromycin, for the treat15 KB (2,008 words) - 16:46, 27 September 2010
- ...for download on [http://www.fda.gov/Drugs/InformationOnDrugs/ucm079750.htm FDA website].</ref> [[generic drug|Generic]] formulations are now available in ...amet.html |archiveurl=http://web.archive.org/web/20071014014507/http://www.fda.gov/oc/qanda/PaxilandAvandamet.html |archivedate=14 October 2007}}</ref> Th66 KB (8,976 words) - 16:47, 27 September 2010
- Valproic acid is also FDA approved for the treatment of [[manic episodes]] associated with [[bipolar | title = FDA Issues Approvable Letter For Stavzor Delayed Release Valproic Acid Capsules25 KB (3,328 words) - 16:47, 27 September 2010
- ...presented a new drug request to the [[U.S. Food and Drug Administration]] (FDA) for fluoxetine.<ref>{{Cite book| last =Breggin| first =Peter R.| coauthors ...ug Administration | month= April | year= 2007| url =http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&TABLE1=OB_Rx | accessd52 KB (7,168 words) - 16:47, 27 September 2010
- ...l adverse effects (approved by the [[U.S. Food and Drug Administration]], "FDA") are deemed insufficient by state courts. ...which reduces risk of surrounding muscle and tissue damage <ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders10 KB (1,347 words) - 21:10, 12 September 2010
- ...ctive therapy" in certain poisoning cases.<ref>{{cite web| url =http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130337.h *[http://www.fda.gov/cder/drug/infopage/prussian_blue/Q&A.htm The FDA's page on prussian blue]20 KB (3,004 words) - 16:47, 27 September 2010
- ...ssion]], which ultimately leads to cell [[lysis]]. Ampicillin has received FDA approval for its action of mechanism.7 KB (881 words) - 16:47, 27 September 2010
- ...Administration. [http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01329.html "FDA Strengthens Labels of Two Specific Types of Antibiotics to Ensure Proper Us4 KB (483 words) - 16:48, 27 September 2010
- ...http://www.merck.com/newsroom/news-release-archive/product/2009_1201a.html FDA Approves Zegerid OTC for Over-the-Counter Treatment of Frequent Heartburn]. ...1995. URL: [http://www.fda.gov/fdac/features/695_prescrip.html http://www.fda.gov/fdac/features/695_prescrip.html]. Accessed on: June 11, 2006.</ref> Un17 KB (2,299 words) - 09:15, 5 September 2010
- On April 25, 2008 the FDA issued a press release<ref>http://www.fda.gov/oc/po/firmrecalls/actavis04_08.html</ref> alerting the public to a Clas On March 31, 2009 the FDA announced another generic digoxin pill recall by posting this company press19 KB (2,738 words) - 16:48, 27 September 2010
- ...ks. The highest approved dose of simvastatin is 80 mg.<ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders ...name="urlInformation on Simvastatin/Amiodarone">{{cite web |url=http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders14 KB (1,967 words) - 16:48, 27 September 2010
- ...lymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=11119 |title=FDA drug information, acetazolamide capsule, extended release | author= | publi12 KB (1,686 words) - 16:48, 27 September 2010
- Under FDA rules, this drug, like many others, excludes eligibility for blood donation11 KB (1,410 words) - 16:49, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in April 2005 mandated that all (including salbutamol) inhalers containing ...re patented. An industry consortium was formed to spread the costs of the FDA safety studies to get propellants such as 134a and 227 approved.<ref>[http:15 KB (2,005 words) - 16:49, 27 September 2010
- ...ww.fda.gov/newsevents/newsroom/pressannouncements/ucm149533.htm]</ref> The FDA only approves metoclopramide for 4-12 week short term treatment. ...=U.S. Food and Drug Administration |date=February 26, 2009 |url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149533.htm |accessdate=2009-011 KB (1,453 words) - 16:49, 27 September 2010
- .../www.rxlist.com/cgi/generic/ibup.htm Motrin (Ibuprofen) drug description - FDA approved labeling for prescription drugs and medications at RxList<!-- Bot ...47.html |title=FDA Approves Caldolor: Cumberland Pharmaceuticals Announces FDA Approval of Caldolor |date=June 11, 2009 |publisher=Drugs.com |accessdate=229 KB (3,955 words) - 22:17, 21 September 2010